Analysis Entera Bio Ltd. WT EXP 062723 (ENTXW)
6/2/2024
Analysis of Entera Bio Ltd. WT EXP 062723 (ENTXW)
Entera Bio Ltd. WT EXP 062723, with the symbol ENTXW, has been showing a downward trend in its stock price over the past few days. The price has been decreasing from 0.02570 on May 31st to 0.00140 on June 27th.Key technical indicators such as the Relative Strength Index (RSI) have been hovering around 40, indicating a neutral sentiment in the market. The Moving Average Convergence Divergence (MACD) indicator has not been providing clear signals due to the lack of data points.
The Moving Averages (MA) analysis shows that the Simple Moving Average (SMA) has been declining, while the Exponential Moving Average (EMA) and Weighted Moving Average (WMA) have not been calculated for some of the recent data points.
Overall, based on the available data, it seems that Entera Bio Ltd. WT EXP 062723 is currently in a consolidation phase with a bearish bias. Traders and investors may want to closely monitor the stock for any potential reversal or breakout signals in the coming days.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31%, with a return on assets of 22.07% and return on equity of 147.25%. The company's fiscal year ends on September 30, 2023.
Regarding stock statistics, the company has a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The stock is held by institutions at 57.59% and insiders at 5.22%, with a short percent of shares outstanding at 0.65%.
Valuation metrics show a PEG ratio of 26.32, forward P/E of 26.32, and trailing P/E of 29.59. The enterprise value is $2.95 trillion, with a market capitalization of $2.92 trillion. The price to book ratio is 39.34, price to sales ratio is 7.65, enterprise to EBITDA ratio is 22.76, and enterprise to revenue ratio is 7.73.
In terms of stock price summary, the company has a beta of 1.26, with a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The stock's 52-week low is $164.08, high is $199.62, and the change over the past 52 weeks is 6.85%.
Lastly, dividends and splits information show a payout ratio of 14.93%, with a forward annual dividend rate of $1 and a trailing annual dividend rate of $0.97. The company's dividend yield is 0.53% on a forward basis and 0.51% on a trailing basis. The last dividend date was on May 16, 2024, and the ex-dividend date is May 10, 2024. The last split date was on August 31, 2020, with a 4-for-1 split.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. The operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. The net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023, showing profitability growth.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
7. The company has been able to maintain a healthy EBITDA margin, indicating operational efficiency.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has generally increased, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its growth.
7. There has been a consistent increase in retained earnings over the years.
8. The company has been managing its short-term debt effectively, as it has not shown a significant increase over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is also an increase from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average estimated EPS is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous year.
4. For the next year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a potential increase from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, showing growth potential in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with expected growth in both quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.6% in the current year and 9.7% in the next year.
- For the current quarter and the next quarter, the growth rate is estimated to be around 5.1%.
- Over the next 5 years, the company is projected to have a compound annual growth rate (CAGR) of approximately 9.7%.
- However, in the past 5 years, the company had a higher growth rate of around 20.1% per annum.
Overall, it seems that the company is expected to maintain a solid growth trajectory, with a slightly lower growth rate in the near term compared to the past performance.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it can be observed that the analysts have a range of opinions regarding the future price of the security, with a low estimate of $164, a high estimate of $275, and an average estimate of $204.58. The current price of the security is $192.25, which falls below the average and median forecasted prices.
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
